At the 2025 Fall Clinical Dermatology Conference, LEO Pharma will unveil its first data presentations on GPP and SPEVIGO since acquiring the product from Boehringer Ingelheim. SPEVIGO is now the third ...

Patients with chronic ulcers who underwent skin grafting had improved graft survival with short-term NPWT with a low rate of serious adverse events.

(A) Oval and elongated yeast-like structures in the deep dermis. (PAS, ×400). (B) Patient’s cat with nasal ulceration diagnosed as sporotrichosis. Only 10 published cases of PGLS were found in the ...

Pyoderma gangrenosum lesion regression after dapsone treatment. However, after two weeks, the patient’s hematological condition deteriorated, presenting with a hemoglobin level of 7 g/dL, white blood ...

“Marta Petersen, MD has specialized expertise in complex medical dermatology. She is board certified in both Internal Medicine and Dermatology and is participating in Maintenance of Certification in ...

InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now. As May came to an end, InflaRx announced that its Phase 3 trial for vilobelimab in pyoderma gangrenosum/PG would be ...

A systematic review of 63 cases found that pyoderma gangrenosum (PG) during pregnancy or postpartum was often misdiagnosed, delaying treatment and leading to inappropriate interventions. Researchers ...

InflaRx N.V. (NASDAQ:IFRX) on Wednesday announced that the Independent Data Monitoring Committee (IDMC) conducting the unblinded interim analysis for the Phase 3 trial for vilobelimab in pyoderma ...

Department of Internal Medicine, Dermatology and Allergology, the Specialist Hospital, Zabrze, Poland Department of Dermatology in Zabrze, Silesian Medical University in Katowice, Poland Pyoderma ...